Colchicine – Recomm

We have insufficient evidence to make a recommendation for use in out-patient settings.

Mild infection

  • Symptomatic (any acute COVID-19 related symptoms
  • AND respiratory rate <24/min
  • WITHOUT pneumonia or hypoxia
We do not recommend use of Colchicine in those hospitalized with COVID-19(strong recommendation)

Mild or moderate illness without hypoxia

  • Pneumonia (clinical or radiological)
  • AND respiratory rate ≤30/min
  • AND SpO2 ≥94% on room air

Moderate illness with hypoxia

NO features of severe or critical illness (see below).

  • Hypoxia (SpO2 <94% on room air)
  • AND respiratory rate ≤30/min
  • AND SpO2 ≥90% on room air

Severe infection

Pneumonia with ANY ONE of the following:

  • respiratory rate >30/min
  • severe respiratory distress
  • SpO2 <90% on room air
  • NO invasive or non-invasive respiratory support needed

Critical infection

  • Requirement for high-level respiratory support: non-invasive ventilation, high-flow oxygen (≥20 litres per minute) or invasive mechanical ventilation
  • OR acute respiratory distress syndrome (PaO2/FiO2 ratio of <300)
  • OR sepsis
  • OR shock